Lilly and Amgen Announce Manufacturing Collaboration for COVID-19 Antibody Therapies

SourceLilly Investors
Date Published09/17/2020
Mentions specific company case(s) of reshoring, kept from offshoring, or transplantYes

Additional Reshoring Information:

Company/Division name Eli Lilly and Company
Type of work Manufacturing
Reshoring category:Reshoring
Year reshoring announced:2020
Year reshoring implemented or to be implemented:2020
City reshored to:Indianapolis
State(s) reshored to:IN
If relevant, work nearshored to:-
Industry(ies):Chemicals, pharmaceutical, biopharmaceutical
Product(s) reshoredneutralizing antibodies, LY-CoV-555
What domestic positive factors made reshoring more attractive?, Covid-19
Find Reshoring Articles